These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6209320)

  • 61. Monoclonal antibodies and autoantibodies in the isolation and characterization of neurotransmitter receptors: the future of receptor research.
    Venter JC
    J Mol Cell Cardiol; 1982 Dec; 14(12):687-93. PubMed ID: 6187930
    [No Abstract]   [Full Text] [Related]  

  • 62. Molecular mimicry and microorganisms: a role in the pathogenesis of myasthenia gravis?
    Dieperink ME; Stefansson K
    Curr Top Microbiol Immunol; 1989; 145():57-65. PubMed ID: 2478337
    [No Abstract]   [Full Text] [Related]  

  • 63. The use of hybridomas to analyse autoimmunity.
    Isenberg DA; Shoenfeld Y; Schwartz RS
    Br Med Bull; 1984 Jul; 40(3):262-6. PubMed ID: 6380637
    [No Abstract]   [Full Text] [Related]  

  • 64. Myasthenia gravis studied by monoclonal antibodies to the acetylcholine receptor.
    Tzartos SJ
    In Vivo; 1988; 2(1):105-10. PubMed ID: 2979808
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Autoimmune T lymphocytes in myasthenia gravis. Determination of target epitopes using T lines and recombinant products of the mouse nicotinic acetylcholine receptor gene.
    Melms A; Chrestel S; Schalke BC; Wekerle H; Mauron A; Ballivet M; Barkas T
    J Clin Invest; 1989 Mar; 83(3):785-90. PubMed ID: 2466050
    [TBL] [Abstract][Full Text] [Related]  

  • 66. TSH receptor antibodies.
    Rees Smith B; Creagh FM; Hashim FA; Howells RD; Jones ED; Kajita Y; Buckland PR; Petersen VB
    Mt Sinai J Med; 1986 Jan; 53(1):53-9. PubMed ID: 3005848
    [No Abstract]   [Full Text] [Related]  

  • 67. Idiotypes and anti-idiotypes in experimental autoimmune myasthenia gravis.
    Souroujon MC; Fuchs S
    Ann N Y Acad Sci; 1986; 475():81-93. PubMed ID: 3491567
    [No Abstract]   [Full Text] [Related]  

  • 68. Immunologic and genetic factors in autoimmune diseases.
    Shoenfeld Y; Schwartz RS
    N Engl J Med; 1984 Oct; 311(16):1019-29. PubMed ID: 6384779
    [No Abstract]   [Full Text] [Related]  

  • 69. Identification of disease-specific autoantibodies in seronegative myasthenia gravis.
    Bartoccioni E; Marino M; Evoli A; Ruegg MA; Scuderi F; Provenzano C
    Ann N Y Acad Sci; 2003 Sep; 998():356-8. PubMed ID: 14592896
    [No Abstract]   [Full Text] [Related]  

  • 70. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
    Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
    J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Standardization of the radioreceptor assay against anti-thyrotrophin receptor antibodies in Graves' disease.
    de Bruin TW; Krol MC; van der Heide D
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):245-51. PubMed ID: 6287780
    [No Abstract]   [Full Text] [Related]  

  • 72. Immune mechanisms in Graves' disease.
    Burman KD; Baker JR
    Endocr Rev; 1985; 6(2):183-232. PubMed ID: 2988930
    [No Abstract]   [Full Text] [Related]  

  • 73. Human muscle acetylcholine receptor reactive T and B lymphocytes in myasthenia gravis.
    Yi Q; Lefvert AK
    Ann N Y Acad Sci; 1993 Jun; 681():339-41. PubMed ID: 8357186
    [No Abstract]   [Full Text] [Related]  

  • 74. [Myasthenia, a model of a disease caused by auto-antibodies].
    Goulon M; Gajdos P; Goulon-Goëau C
    Ann Med Interne (Paris); 1987; 138(6):444-61. PubMed ID: 2829682
    [No Abstract]   [Full Text] [Related]  

  • 75. Further characterization of a high affinity thyrotropin binding site on the rat thyrotropin receptor which is an epitope for blocking antibodies from idiopathic myxedema patients but not thyroid stimulating antibodies from Graves' patients.
    Kosugi S; Ban T; Akamizu T; Kohn LD
    Biochem Biophys Res Commun; 1991 Oct; 180(2):1118-24. PubMed ID: 1719963
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Thyrotropin receptor epitopes recognized by graves' autoantibodies developing under immunosuppressive therapy.
    Wortsman J; McConnachie P; Tahara K; Kohn LD
    J Clin Endocrinol Metab; 1998 Jul; 83(7):2302-8. PubMed ID: 9661599
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Region of peptide 125-147 of acetylcholine receptor alpha subunit is exposed at neuromuscular junction and induces experimental autoimmune myasthenia gravis, T-cell immunity, and modulating autoantibodies.
    Lennon VA; McCormick DJ; Lambert EH; Griesmann GE; Atassi MZ
    Proc Natl Acad Sci U S A; 1985 Dec; 82(24):8805-9. PubMed ID: 3878521
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Determinant selection in murine experimental autoimmune myasthenia gravis. Effect of the bm12 mutation on T cell recognition of acetylcholine receptor epitopes.
    Infante AJ; Thompson PA; Krolick KA; Wall KA
    J Immunol; 1991 May; 146(9):2977-82. PubMed ID: 1707927
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Antibodies of the TSH receptor in Graves' disease (author's transl)].
    Smith BR
    Horumon To Rinsho; 1982 Jan; 30(1):45-6. PubMed ID: 6280910
    [No Abstract]   [Full Text] [Related]  

  • 80. Molecular anatomy of an autoantigen: T and B epitopes on the nicotinic acetylcholine receptor in myasthenia gravis.
    Manfredi AA; Protti MP; Bellone M; Moiola L; Conti-Tronconi BM
    J Lab Clin Med; 1992 Jul; 120(1):13-21. PubMed ID: 1377215
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.